Targeting Glutamine Metabolism in MYC Driven Atypical Teratoid Rhabdoid Tumors |
The Johns Hopkins University School of Medicine / Jeffrey Rubens, MD |
Young Investigator Grants |
2017 |
Maryland |
Targeting Protein Translation to Antagonize MYC-driven Neuroblastoma |
Children’s Hospital of Philadelphia / Andrea Flynn, MD |
Young Investigator Grants |
2017 |
Pennsylvania |
Identification and Targeting of Microenvironmental Factors Controlling Pediatric Leukemia |
New York University School of Medicine / Anastasia Tikhonova, PhD |
Young Investigator Grants |
2017 |
New York |
Cancer Susceptibility and Signaling Pathways in Low-Grade Brain Tumors |
Jewish General Hospital / Bárbara Rivera, PhD |
Young Investigator Grants |
2017 |
Quebec |
Understanding the Mechanisms of HOX Gene Regulation in Normal and Leukemic Hematopoietic Stem Cells to Identify New Therapies for Pediatric AML |
Boston Children’s Hospital / Anne Robertson, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Overcoming Glucocorticoid Resistance in Lymphoid Cancers |
University of California San Francisco / Anica Wandler, PhD |
Young Investigator Grants |
2017 |
California |
Anthracycline-Induced Cardiac Toxicity in Pediatric Acute Myeloid Leukemia |
University of Pennsylvania / Kelly Getz, PhD |
Young Investigator Grants |
2017 |
Pennsylvania |
Preclinical Efficacy of Daratumumab in T Cell Acute Lymphoblastic Leukemia |
New York University School of Medicine / Karen Bride, MD/PhD |
Young Investigator Grants |
2017 |
New York |
Identification and Characterization of Pathways Dysregulated by MMSET E1099K Mutation in Relapsed Pediatric Acute Lymphoblastic Leukemia and Their Role in Drug Resistance |
New York University School of Medicine / Joanna Pierro, DO |
Young Investigator Grants |
2017 |
New York |
Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions |
Dana-Farber Cancer Institute / Cecile Rouleau, PhD |
Young Investigator Grants |
2017 |
Massachusetts |